Ayala Pharmaceuticals, Inc.
ADXSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001100397
Ayala Pharmaceuticals, Inc. was delisted in 2025; its insiders filed their last Form 4 on Mar 6, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Ayala Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 14.1K | 0 | −14.1K (−100.0%) |
| Value | $46.0K | $0 | −$46.0K (−100.0%) |
New holders (0)
Institutions that held Ayala Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (1)
Institutions that held Ayala Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fifth Lane Capital, LP | 14,102 | $46.0K |